Bret Kenwell

Bret Kenwell

Expertise: Automotive Stocks, Growth Stocks, Tech Stocks, Dividends

Education: Studied finance at Central Michigan University

About Bret:
Bret Kenwell has been publicly writing about and analyzing the stock market for more than 10 years. What started off as fundamental analysis of strong businesses has morphed into a rigorous process that blends both fundamental and technical analysis.

While he still seeks out the strong businesses and dependable dividends he was attracted to early on, Bret has narrowed his focus to technology, automotive, and high-quality, high-growth businesses.

In that effort, he seeks Future Blue Chips — which is also the name of his website and newsletter.

Bret’s writing has sent him to unique places and events, like auto shows and industry conferences. Those excursions allowed him to fully grasp what Nvidia was showcasing at its GTC conferences and see some of the impressive updates on display at the automotive show. Through this he gained incredible insight into, and conviction in, what have become some of today’s best-performing stocks.

It’s also allowed him to meet some very smart, very talented investors — both here on InvestorPlace and elsewhere. Perhaps more than anything, their lessons, findings and techniques have found a way into his process over the years.

There are a million different ways to make money in the stock market. To find the process that works best for you is long and filled with setbacks. Bret’s hope is that part of his process can become part of yours; and together become better investors.

You can follow Bret on Twitter and on LinkedIn.

Recent Articles

Why Is Jumia (JMIA) Stock Down 15% Today?

Jumia is hitting new 52-week lows on the day, as JMIA stock slumps 15% on Monday. The news comes amid a management shakeup.

What Is Going on With Peak Bio (PKBO) Stock Today?

Peak Bio stock is ripping higher on the day, with PKBO stock up more than 100% on Friday. This move adds to the recent volatility.

Why Is Provention Biosciences (PRVB) Stock Up 25% Today?

Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab.

Why Is CanSino Biologics (CASBF) Stock Soaring Today?

CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.

INTU Stock Drops 9% as Intuit Pauses Hiring

Intuit will pause hiring at its Credit Karma business, but investors aren't liking the news as INTU stock plummets 9% on Tuesday.